NasdaqGS - Nasdaq Real Time Price USD

Walgreens Boots Alliance, Inc. (WBA)

Compare
10.28 -1.18 (-10.30%)
At close: 31 de enero, 4:00:01 p.m. EST
9.96 -0.32 (-3.11%)
Pre-Market: 9:10:59 a.m. EST
Loading Chart for WBA
DELL
  • Previous Close 11.46
  • Open 9.93
  • Bid 10.27 x 100
  • Ask 10.90 x 100
  • Day's Range 9.52 - 10.75
  • 52 Week Range 8.08 - 23.77
  • Volume 91,510,553
  • Avg. Volume 25,680,305
  • Market Cap (intraday) 8.883MM
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) --
  • EPS (TTM) -10.24
  • Earnings Date 26 mar 2025 - 31 mar 2025
  • Forward Dividend & Yield 1.00 (10.85%)
  • Ex-Dividend Date 18 nov 2024
  • 1y Target Est 12.35

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

www.walgreensbootsalliance.com

193,000

Full Time Employees

31-agosto

Fiscal Year Ends

Recent News: WBA

View More

Performance Overview: WBA

Trailing total returns as of 31/1/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

WBA
11.02%
S&P 500
2.26%

1-Year Return

WBA
51.14%
S&P 500
22.65%

3-Year Return

WBA
75.28%
S&P 500
36.30%

5-Year Return

WBA
73.97%
S&P 500
83.96%

Compare To: WBA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WBA

View More

Valuation Measures

As of 31/1/2025
  • Market Cap

    8.88B

  • Enterprise Value

    38.40B

  • Trailing P/E

    --

  • Forward P/E

    6.90

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.06

  • Price/Book (mrq)

    0.89

  • Enterprise Value/Revenue

    0.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.85%

  • Return on Assets (ttm)

    0.59%

  • Return on Equity (ttm)

    -75.97%

  • Revenue (ttm)

    147.66MM

  • Net Income Avi to Common (ttm)

    -8.64MM

  • Diluted EPS (ttm)

    -10.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.11MM

  • Total Debt/Equity (mrq)

    277.90%

  • Levered Free Cash Flow (ttm)

    2.73MM

Research Analysis: WBA

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 39.46MM
Earnings -265M
Q1'24
Q2'24
Q3'24
Q4'24
0
10 mil M
20 mil M
30 mil M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

7.00 Low
12.35 Average
10.28 Current
20.00 High
 

People Also Watch